SJM Scenario Analysis — 2026-08-20
SJM scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
CAMS Premium Report
Zoom: Quality Meets an Earnings-Day Proof Point
ZM scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
RY Scenario Analysis — 2026-08-20
RY scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
MiniMed: Product Momentum Meets an Earnings Test
MMED scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
Rubrik: Growth Quality Meets an Earnings Valuation Test
RBRK scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
BBY: The Earnings Test Behind the AI-Device Narrative
BBY scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
CMB.Tech: Strong Tape, Hard Questions Ahead of Earnings
CMBT scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
Everpure (P): Hyperscaler Evidence Meets an Earnings Test
P scenario analysis covering evidence, valuation, catalysts, risks, and monitoring conditions.
HEICO: Quality Meets a Demanding Bar
HEICO combines exceptional operating performance with a valuation that demands durable execution. This scenario review maps the evidence around the August 25 update.
Affirm Holdings: The Earnings Scenario Map
A Level 2+ scenario analysis of Affirm Holdings ahead of its August 27 update. Market analysis, not personalized advice.